Curated News
By: NewsRamp Editorial Staff
October 21, 2025

Hydromer Reports 11% Revenue Growth, Returns to Profitability in Q3 2025

TLDR

  • Hydromer's 11% revenue growth and return to profitability demonstrates strong market positioning and potential stock value recovery as they upgrade to OTCID Basic Market.
  • Hydromer achieved $0.91 million Q3 2025 revenue with $53,000 net income through operational efficiency, infrastructure investment, and new customer acquisition strategies.
  • Hydromer's medical coating technologies improve patient safety worldwide while their growth creates sustainable jobs and advances healthcare innovation for future generations.
  • After 44 years in medical coatings, Hydromer combines revenue growth with profit while developing next-generation technologies from their ISO-certified facilities.

Impact - Why it Matters

This financial turnaround demonstrates the growing demand for advanced medical device coatings and surface modification technologies. As healthcare continues to prioritize infection control and device performance, companies like Hydromer play a crucial role in developing coatings that prevent blood clots, resist microbial growth, and improve device functionality. The company's return to profitability and planned market relisting could signal improved stability and growth potential in the medical technology sector, potentially benefiting healthcare providers and patients through enhanced medical device safety and performance.

Summary

Hydromer, Inc. (OTC: HYDI), a pioneering surface modification and coating technology company with over 44 years of experience, has announced preliminary unaudited financial results for the third quarter ended September 30, 2025. The Concord, North Carolina-based company reported revenue of $0.91 million, representing an 11% increase compared to the $0.81 million generated in the same quarter of 2024. More significantly, Hydromer returned to profitability with net income of $53,000, marking a positive turnaround for the medical device coating specialist. These results, while preliminary and subject to final audit adjustments, demonstrate the company's continued growth trajectory and operational improvements under CEO Michael Torti's leadership.

CEO Michael Torti expressed satisfaction with the company's performance, highlighting both the top-line growth and return to profitability. He emphasized Hydromer's strong customer loyalty and noted the emergence of growth from new customers entering the company's production coating lineup. Torti also addressed the company's strategic priorities, including ongoing investments in infrastructure and equipment while maintaining a strong focus on new product development. Importantly, he acknowledged the "artificially low valuation" of HYDI stock and associated trading difficulties, announcing plans to return the company to the OTCID Basic Market to improve shareholder value and market accessibility. The company remains committed to building a scalable, innovation-driven platform while prioritizing operational efficiency, customer partnerships, and next-generation technology development.

As an ISO 9001:2015 certified global business-to-business provider, Hydromer offers comprehensive surface modification solutions across multiple industries, with particular expertise in medical device coatings featuring hydrophilic, thromboresistant, and antimicrobial properties. The company maintains facilities compliant with Good Manufacturing Practice (GMP), ISO 13485, and ISO 9001 standards, serving customers across the United States, Europe, and Asia-Pacific regions. Hydromer's diverse service portfolio includes proprietary coating formulations, custom coating services, research and development, analytical testing, technology transfer, and dedicated machinery building and support. The company's four decades of experience have resulted in numerous proprietary formulations and worldwide patents, positioning it as a trusted partner in advanced coating technologies. Readers can view the original release on www.newmediawire.com for complete details.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Hydromer Reports 11% Revenue Growth, Returns to Profitability in Q3 2025

blockchain registration record for this content.